연구동향 분석

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression

조남훈 최재윤 한현호 김영태 이주현 김백길 강수기 2017년

논문상세정보
인용/피인용

' Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression' 의 참고문헌

  • Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells
    Tomassetti A Neoplasia 10 1481-1492 [2008]
  • Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group
    Yamamoto S Int J Gynecol Pathol 30 129-138 [2011]
  • The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
    Zeppernick F Arch Gynecol Obstet 290 839-842 [2014]
  • The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest
    Nagl NG Jr Cancer Res 66 1289-1293 [2006]
  • The SWI/SNF complex and cancer
    Reisman D Oncogene 28 1653-1668 [2009]
  • The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
    Chene G Int J Gynaecol Obstet 130 27-30 [2015]
  • SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation
    Banine F Cancer Res 65 3542-3547 [2005]
  • Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription
    Yan HB Carcinogenesis 35 867-876 [2014]
  • Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
    Faleiro-Rodrigues C Ann Oncol 15 1535-1542 [2004]
  • Prognostic significance of histological grade in clear-cell carcinoma of the ovary:a retrospective study of Korean Gynecologic Oncology Group
    Ryu SY Ann Oncol 20 1032-1036 [2009]
  • Prognosis of ovarian clear cell carcinoma compared to other histological subtypes:a meta-analysis
    Lee YY Gynecol Oncol 122 541-547 [2011]
  • Overexpression of Mucin 13 due to Promoter Methylation Promotes Aggressive Behavior in Ovarian Cancer Cells
    성혜윤 Yonsei Medical Journal 55 5 1206-1213 [2014]
  • Ovarian tumors associated with atypical endometriosis
    LaGrenade A Hum Pathol 19 1080-1084 [1988]
  • Molecular pathogenesis of ovarian clear cell carcinoma
    Gounaris I Future Oncol 11 1389-1405 [2015]
  • Modulation of estrogenic action in clear cell carcinoma of the ovary (review)
    Tanase Y Exp Ther Med 3 18-24 [2012]
  • Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    Xiao W Int J Clin Exp Pathol 5 642-650 [2012]
  • Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
    Yamamoto S Mod Pathol 25 615-624 [2012]
  • Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary
    Itamochi H Int J Clin Oncol 20 967-973 [2015]
  • Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
    Ayhan A Int J Gynecol Cancer 22 1310-1315 [2012]
  • Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors
    Inoue H J Biol Chem 277 41674-41685 [2002]
  • Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma
    Lin K Acta Histochem 116 878-882 [2014]
  • Gynecologic cancers: molecular updates
    Ahmed Q Clin Lab Med 33 911-925 [2013]
  • Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary
    Okamoto A Int J Gynecol Cancer 24 9 Suppl 3 S20-S25 [2014]
  • Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
    Jones S Science 330 228-231 [2010]
  • Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
    Tsuchiya A Am J Pathol 163 2503-2512 [2003]
  • Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis
    Lazennec G Cancer Lett 231 151-157 [2006]
  • Epithelial abnormalities in cystic ovarian endometriosis
    Prefumo F Gynecol Oncol 84 280-284 [2002]
  • Epigenetic determinants of ovarian clear cell carcinoma biology
    Yamaguchi K Int J Cancer 135 585-597 [2014]
  • Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
    Shen H Nat Commun 4 1628- [2013]
  • DNA methylation changes in epithelial ovarian cancer histotypes
    Earp MA Genomics 106 311-321 [2015]
  • DNA Hypomethylation-Mediated Overexpression of Carbonic Anhydrase 9 Induces an Aggressive Phenotype in Ovarian Cancer Cells
    안정혁 Yonsei Medical Journal 55 6 1656-1663 [2014]
  • Clinicopathologic significance of HNF-1β, AIRD1A, and PIK3CA expression in ovarian clear cell carcinoma: a tissue microarray study of 130 cases
    Ye S Medicine (Baltimore) 95 e3003- [2016]
  • Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
    Rahman M Hum Pathol 44 103-109 [2013]
  • ARID1A mutations in endometriosis-associated ovarian carcinomas
    Wiegand KC N Engl J Med 363 1532-1543 [2010]
  • ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas
    Samartzis EP Int J Mol Sci 14 18824-18849 [2013]